PP
CTSO icon

Pegasus Partners’s Cytosorbents Corp CTSO Stock Holding History

Pegasus Partners’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,000
Closed -$66K – 183
2019
Q2 		$66K Hold
10,000
– – 0.02% 170
2019
Q1 		$76K Hold
10,000
– – 0.02% 135
2018
Q4 		$81K Sell
10,000
-215
-2% -$2.13K 0.02% 134
2018
Q3 		$132K Buy
10,215
+215
+2% +$2.69K 0.03% 136
2018
Q2 		$114K Buy
+10,000
New +$94.7K 0.03% 142

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Pegasus Partners's CTSO Position: Q3 2019 in Review

Pegasus Partners sold out of Cytosorbents Corp (CTSO) in Q3 2019, closing a stake of 10,000 shares — an estimated $66K sold.

Pegasus Partners first reported a position in CTSO in Q2 2018 and held it in 5 quarters. The position peaked at $132K in Q3 2018. 69 funds tracked by Wall St. Rank hold CTSO as of Q3 2019.

  • Pegasus Partners reported no remaining Cytosorbents Corp position as of Q3 2019 after selling out during the quarter.
  • Pegasus Partners sold 10,000 Cytosorbents Corp shares in Q3 2019, an estimated $66K.
  • Pegasus Partners first reported a position in Cytosorbents Corp in Q2 2018 and held it in 5 quarters.
  • Pegasus Partners's Cytosorbents Corp position peaked at $132K in Q3 2018.
  • 69 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2019.

Based on Pegasus Partners's 13F filing for Q3 2019, filed 24 Oct 2019.